Digitala Vetenskapliga Arkivet

Ändra sökning
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Diastereoselective Synthesis of N-Methylspiroindolines by Intramolecular Mizoroki–Heck Annulations
Uppsala universitet, Medicinska och farmaceutiska vetenskapsområdet, Farmaceutiska fakulteten, Institutionen för läkemedelskemi.ORCID-id: 0000-0003-4795-6117
Uppsala universitet, Medicinska och farmaceutiska vetenskapsområdet, Farmaceutiska fakulteten, Institutionen för läkemedelskemi.
Uppsala universitet, Medicinska och farmaceutiska vetenskapsområdet, Farmaceutiska fakulteten, Institutionen för läkemedelskemi.
Uppsala universitet, Medicinska och farmaceutiska vetenskapsområdet, Farmaceutiska fakulteten, Institutionen för läkemedelskemi.ORCID-id: 0000-0002-2885-2016
Visa övriga samt affilieringar
2022 (Engelska)Ingår i: ACS Omega, E-ISSN 2470-1343, Vol. 7, nr 36, artikel-id 32525Artikel i tidskrift (Refereegranskat) Published
Abstract [en]

Spiroindolines represent a privileged structure in medicinal chemistry, although stereocontrol around the spirocarbon can be a synthetic challenge. Here we present a palladium(0)-catalyzed intramolecular Mizoroki–Heck annulation reaction from (+)-Vince lactam-derived cyclopentenyl-tethered 2-bromo-N-methylanilines for the formation of N-methylspiroindolines. A series of 14 N-methylspiroindolines were synthesized in 59–81% yield with diastereoselectivity >98%, which was rationalized by density functional theory calculations and confirmed through X-ray crystallography. One spiroindoline was converted to an N- and C-terminal protected rigidified unnatural amino acid, which could be orthogonally deprotected.

Ort, förlag, år, upplaga, sidor
American Chemical Society (ACS), 2022. Vol. 7, nr 36, artikel-id 32525
Nationell ämneskategori
Läkemedelskemi Fysik
Forskningsämne
Läkemedelskemi
Identifikatorer
URN: urn:nbn:se:uu:diva-489619DOI: 10.1021/acsomega.2c04111ISI: 000860372600001PubMedID: 36120037OAI: oai:DiVA.org:uu-489619DiVA, id: diva2:1715411
Forskningsfinansiär
Uppsala universitetTillgänglig från: 2022-12-01 Skapad: 2022-12-01 Senast uppdaterad: 2023-03-22Bibliografiskt granskad
Ingår i avhandling
1. Palladium(0)-Catalyzed Spirocyclization and Carbonylation Reactions: Ligands Targeting the Angiotensin II Type 2 Receptor
Öppna denna publikation i ny flik eller fönster >>Palladium(0)-Catalyzed Spirocyclization and Carbonylation Reactions: Ligands Targeting the Angiotensin II Type 2 Receptor
2023 (Engelska)Doktorsavhandling, sammanläggning (Övrigt vetenskapligt)
Abstract [en]

Palladium(0)-catalyzed chemistry represents one of the most important methods for the construction of carbon-carbon bonds, which are ubiquitous in organic compounds. The first part of this thesis describes the palladium(0)-catalyzed diastereoselective Mizoroki-Heck reaction of Vince lactam-derived precursors for the formation of spiroindolines (paper I) and spirooxindoles, which are scaffolds present in several natural products with interesting biological activity. The scope of the spiroindoline synthesis was investigated by varying the substitution on the cyclopentenyl-tethered aniline spirocyclization precursor. The mechanistic reasons behind the high diastereoselectivity of the spirocyclization reaction was also investigated through density functional theory (DFT) calculations. 

Functionalization of the N-terminal amino acid of therapeutic peptides is a strategy that has been employed for the improvement of metabolic stability. In paper II, a palladium(0)-catalyzed carbonylation method employing ex situ carbon monoxide generation from Mo(CO)6 in a two-chamber system is used for the N-capping of amino acids using various aryl bromides and triflates. 

The second part of the thesis describes the synthesis and biological evaluation of angiotensin II type 2 receptor (AT2R) ligands. The AT2R is a G-protein coupled receptor belonging to the renin-angiotensin-aldosterone system (RAAS), which is most commonly associated with the hypertensive disorder caused by an exaggerated activation of the angiotensin II type 1 receptor (AT1R). However, activation of AT2R exerts different and sometimes completely opposing effects to AT1R and has been implicated in processes related to neuropathic pain, where the AT2R antagonist EMA401 has been in clinical trials for this indication. In papers III and IV, the AT2R antagonist C38 developed in our laboratory, is used as a model compound for the synthesis of analogs with the aim of expanding our knowledge regarding the structure-activity relationship of the C38 scaffold. Three general strategies were used; functionalization of the C38 phenyl ring, replacement of the benzyl imidazole of C38 with bicyclic amides and extension of the linker between the phenyl ring and imidazole by the inclusion of a carbonyl. Through these approaches, compounds with improved affinity towards AT2R and increased metabolic stability were identified, which might serve as tools for the continued study of the AT2R.

Ort, förlag, år, upplaga, sidor
Uppsala: Acta Universitatis Upsaliensis, 2023. s. 110
Serie
Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Pharmacy, ISSN 1651-6192 ; 331
Nyckelord
Palladium catalysis, Mizoroki-Heck reaction, spiroindolines, spirooxindoles, amino acids, carbonylation, angiotensin II type 2 receptor, AT2R ligands
Nationell ämneskategori
Organisk kemi Läkemedelskemi
Forskningsämne
Läkemedelskemi
Identifikatorer
urn:nbn:se:uu:diva-498995 (URN)978-91-513-1766-3 (ISBN)
Disputation
2023-05-12, A1:107a, BMC, Husargatan 3, Uppsala, 09:15 (Engelska)
Opponent
Handledare
Tillgänglig från: 2023-04-19 Skapad: 2023-03-22 Senast uppdaterad: 2023-04-19

Open Access i DiVA

fulltext(2420 kB)545 nedladdningar
Filinformation
Filnamn FULLTEXT01.pdfFilstorlek 2420 kBChecksumma SHA-512
09c8b2479b0d7737b27e2f4cec9859356df5e1d7834aac8d39dd0dc2806520bd01095ec082ee3f37df10ad8827e1dec2bb7b06bbaac57479f174267ed4568d08
Typ fulltextMimetyp application/pdf

Övriga länkar

Förlagets fulltextPubMed

Sök vidare i DiVA

Av författaren/redaktören
Lindman, JensPalo-Nieto, CarlosBrandt, PeterGising, JohanLarhed, Mats
Av organisationen
Institutionen för läkemedelskemi
I samma tidskrift
ACS Omega
LäkemedelskemiFysik

Sök vidare utanför DiVA

GoogleGoogle Scholar
Totalt: 547 nedladdningar
Antalet nedladdningar är summan av nedladdningar för alla fulltexter. Det kan inkludera t.ex tidigare versioner som nu inte längre är tillgängliga.

doi
pubmed
urn-nbn

Altmetricpoäng

doi
pubmed
urn-nbn
Totalt: 251 träffar
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf